What is the latest market price of Erdafitinib in 2025?

Erdafitinib (Erdafitinib) is an oral small molecule targeted drug that mainly belongs to the fibroblast growth factor receptor (FGFR) inhibitor class. It was originally developed to target changes in the FGFR gene in some tumor patients, especially in advanced urothelial cancer (bladder cancer), where FGFR2 or FGFR3 mutations are common. Traditional chemotherapy has limited efficacy for these patients, and erdafitinib blocks the FGFR pathway and cuts off cancer cell growth signals, providing new possibilities for precision treatment. With the development of global precision medicine, the drug has gained widespread attention from clinicians in both overseas and domestic markets.

In China, erdafitinib has been launched on the market, with main specifications:5mg 28 tablets, 3mg 56 tablets and 4mg*28 tablets. Because it is an imported drug recently introduced into the market, it has not yet been included in the national medical insurance catalog, which means that patients need to bear the cost of treatment at their own expense. From a price point of view, the supply of domestic pharmacies is still relatively limited, and some patients will purchase drugs through overseas channels. The prices of original drugs in the Hong Kong market are relatively transparent, with each box often costing more than 20,000 yuan. Prices fluctuate due to exchange rates, channels and regional policies.

Compared with the original drug, some overseas generic versions of erdafitinib are gradually attracting the attention of patients. For example, pharmaceutical factories in Laos and Bangladesh have launched generic drugs. The active ingredients and dosage design of these drugs are consistent with the original drug. However, due to differences in production and channels, the selling price is significantly lower, generally ranging from a few hundred yuan to more than 2,000 yuan. This provides an alternative for patients under financial pressure. However, it should be noted that when choosing generic drugs, you must go through formal channels to ensure the quality and safety of the drugs.

Reference materials：https://www.balversa.com/